Multiple doses
Showing 1 - 25 of >10,000
Helicobacter Pylori Infection Trial in Chang chun (TNP-2198, Rabeprazole Sodium, Amoxicillin)
Completed
- Helicobacter Pylori Infection
- TNP-2198
- +2 more
-
Chang chun, Jilin, ChinaThe First Hospital of Jilin University
Oct 7, 2023
Healthy Participants Trial in Neuss (NNC0113-6856, Placebo)
Not yet recruiting
- Healthy Participants
- NNC0113-6856
- Placebo
-
Neuss, GermanyNovo Nordisk Investigational Site
Sep 29, 2023
Multiple Sclerosis Trial in San Antonio (PIPE-791, Placebo)
Recruiting
- Multiple Sclerosis
- PIPE-791
- Placebo
-
San Antonio, TexasWorldwide Clinical Trials
Jul 31, 2023
Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Multiple Dose Insulin Therapy
- Personalized treatment
- (no location specified)
Nov 18, 2023
COVID-19 Trial in London (ALG-097558, Placebo, Midazolam)
Not yet recruiting
- COVID-19
- ALG-097558
- +6 more
-
London, United KingdomHammersmith Medicines Research
Apr 21, 2023
Healthy Volunteers Trial in Nedlands (VG290131)
Recruiting
- Healthy Volunteers
-
Nedlands, Western Australia, AustraliaLinear Clinical Research Ltd
Oct 17, 2023
Healthy Trial (BI 3802876, Placebo matching BI 3802876)
Not yet recruiting
- Healthy
- BI 3802876
- Placebo matching BI 3802876
- (no location specified)
Oct 16, 2023
Healthy Trial in Mannheim (Microgynon®, BI 425809)
Recruiting
- Healthy
- Microgynon®
- BI 425809
-
Mannheim, GermanyCRS Clinical Research Services Mannheim GmbH
Jan 30, 2023
Healthy Volunteers Trial in Anaheim (MYK-224, Placebo)
Completed
- Healthy Volunteers
- MYK-224
- Placebo
-
Anaheim, CaliforniaLocal Institution - 0001
Jan 12, 2023
Atherosclerosis, Ischemic Stroke Trial in Nottingham (SP-8356, Placebo)
Terminated
- Atherosclerosis
- Ischemic Stroke
- SP-8356
- Placebo
-
Nottingham, Mere Way Ruddington Fields Ruddington, United KingdomQuotient Sciences
Oct 6, 2022
Healthy Trial (BI 1839100, Placebo matching BI 1839100)
Not yet recruiting
- Healthy
- BI 1839100
- Placebo matching BI 1839100
- (no location specified)
Feb 13, 2023
Healthy Subjects Trial in Christchurch (EC5026 oral tablet, Placebo oral tablet)
Not yet recruiting
- Healthy Subjects
- EC5026 oral tablet
- Placebo oral tablet
-
Christchurch, New ZealandNew Zealand Clinical Research
Oct 17, 2023
Healthy Trial in Randwick (Hemay005 60 mg)
Not yet recruiting
- Healthy
- Hemay005 60 mg
-
Randwick, New South Wales, AustraliaScientia Clinical Research Ltd
Jul 3, 2023
Healthy Subjects Trial in Austin (Vorasidenib 40 mg Oral Tablet, Ciprofloxacin 500 mg Oral Tablet, Vorasidenib 10 mg Oral
Recruiting
- Healthy Subjects
- Vorasidenib 40 mg Oral Tablet
- +2 more
-
Austin, TexasPPD Development
May 3, 2023
Helicobacter Pylori Infection Trial in Chang chun (TNP-2198, Rabeprazole Sodium, Amoxicillin)
Completed
- Helicobacter Pylori Infection
- TNP-2198
- +2 more
-
Chang chun, Jilin, ChinaThe First Hospital of Jilin University
Oct 7, 2023
Respiratory Syncytial Virus Infections Trial in Changsha (XW001, Placebo)
Completed
- Respiratory Syncytial Virus Infections
- XW001
- Placebo
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Nov 30, 2022
Multiple System Atrophy (MSA) Trial in Fountain Valley (ONO-2808, Placebo)
Not yet recruiting
- Multiple System Atrophy (MSA)
- ONO-2808
- Placebo
-
Fountain Valley, CaliforniaThe Parkinson's Movement and Disorder Institute
Jun 20, 2023
Immune System Disorder (Healthy Volunteer) Trial in Buffalo (Belumosudil mesylate, Placebo)
Completed
- Immune System Disorder (Healthy Volunteer)
- Belumosudil mesylate
- Placebo
-
Buffalo, New YorkInvestigational site
Jun 15, 2023
Healthy Volunteers Trial in Toronto (ION547, Placebo)
Completed
- Healthy Volunteers
- ION547
- Placebo
-
Toronto, Ontario, CanadaBioPharma Services, Inc.
Sep 21, 2022